GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (NAS:NVCN) » Definitions » Net Margin %

Neovasc (Neovasc) Net Margin % : -952.58% (As of Dec. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Neovasc Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Neovasc's Net Income for the three months ended in Dec. 2022 was $-13.84 Mil. Neovasc's Revenue for the three months ended in Dec. 2022 was $1.45 Mil. Therefore, Neovasc's net margin for the quarter that ended in Dec. 2022 was -952.58%.

The historical rank and industry rank for Neovasc's Net Margin % or its related term are showing as below:

NVCN' s Net Margin % Range Over the Past 10 Years
Min: -6173.99   Med: -943.21   Max: -57.46
Current: -1082.92


NVCN's Net Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.045 vs NVCN: -1082.92

Neovasc Net Margin % Historical Data

The historical data trend for Neovasc's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovasc Net Margin % Chart

Neovasc Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,173.99 -1,679.30 -1,466.27 -977.19 -1,082.89

Neovasc Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -810.67 -1,662.68 -1,097.56 -891.33 -952.58

Competitive Comparison of Neovasc's Net Margin %

For the Medical Devices subindustry, Neovasc's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neovasc's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neovasc's Net Margin % distribution charts can be found below:

* The bar in red indicates where Neovasc's Net Margin % falls into.



Neovasc Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Neovasc's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-41.204/3.805
=-1,082.89 %

Neovasc's Net Margin for the quarter that ended in Dec. 2022 is calculated as

Net Margin=Net Income (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-13.841/1.453
=-952.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neovasc  (NAS:NVCN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Neovasc Net Margin % Related Terms

Thank you for viewing the detailed overview of Neovasc's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neovasc (Neovasc) Business Description

Traded in Other Exchanges
N/A
Address
13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

Neovasc (Neovasc) Headlines

From GuruFocus

Neovasc Announces German Reimbursement Renewal

By Stock market mentor Stock market mentor 02-01-2023

Neovasc to Participate in H.C. Wainwright Global Investment Conference

By GuruFocusNews GuruFocusNews 06-22-2022

Neovasc Announces Direct Sales Operations in United Kingdom

By PurpleRose PurpleRose 07-15-2022

Neovasc Comments on European Heart Journal Publication

By Value_Insider Value_Insider 11-18-2022

Shockwave Medical to Acquire Neovasc

By Stock market mentor Stock market mentor 01-17-2023

Neovasc to Participate in H.C. Wainwright Global Investment Conference

By GuruFocusNews GuruFocusNews 06-12-2022